12:00 AM
 | 
Nov 23, 2015
 |  BC Week In Review  |  Company News  |  Deals

Alexza, Teva deal

Alexza will regain U.S. rights to Adasuve loxapine from Teva, effective Jan. 1, 2016. Alexza, which granted Teva U.S rights in 2013, said it plans to identify a...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >